Search

everythinglearnresearchcommunity

for

Search:↓

New compounds were made and tested, with compound 6 showing potential for treating prostate-related diseases.

SSAT is a key enzyme affecting cell growth and metabolism, with potential but risky use in disease treatment.

Two new compounds were found to build bone and muscle without affecting reproductive organs and skin oil glands.

Finasteride lowers DHT levels and raises testosterone in a dose-dependent way.

The system allows precise control of gene expression in mouse skin, useful for studying skin biology.

Targeting CD200 could be a new treatment for rheumatoid arthritis.

pCLCA2 protein may help maintain skin structure and function.

Scientists found a new protein, AMY117, common in Alzheimer's patients, which could be important for treatment and diagnosis.

The hr gene is linked to hair loss in Valle del Belice sheep.

HDAC inhibitors help brain cells grow and improve brain function.

A rare genetic mutation caused severe symptoms in a 6-year-old girl with mandibuloacral dysplasia type A.

Researchers found a new mutation causing total hair loss from birth.

Increased HSD11B1 enzyme expression is linked to higher body fat and insulin resistance.

ALRV5XR effectively increases hair density in men with androgenetic alopecia without adverse effects.

A new enzyme in rats may help regulate hair growth.

A new mutation in the KRT86 gene causes a hair disorder with variable expression.

NKG2D gene polymorphism doesn't affect SLE risk but may influence symptoms like rash and hair loss.

Testosterone needs to be converted to DHT to reduce stress response in male rats.

Lrig1 could be a marker for advanced sebaceous carcinoma.

A new compound effectively inhibits human 5α-reductase 1.

FGF5 gene mutations cause unusually long eyelashes by affecting hair growth regulation.

SFRP2 and PTGDS may be key factors in female hair loss.

Overexpressing SSAT enzyme reduces prostate tumor growth in mice.

The vitamin D receptor is crucial for bone health and affects various body systems, with mutations potentially leading to disease.

Blocking 5α-reductase can harm memory and brain structure, and increase harmful brain changes in male mice used for Alzheimer's disease research.

Researchers found an RNA transcript that might help control a growth factor linked to tumor development.

5α-reductase inhibitors may worsen sexual drive and spontaneous erections but don't worsen existing erectile or ejaculatory problems.

A reliable model for screening type II 5α-reductase inhibitors was created and validated.